title: Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
authors.affiliation: Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Portugal.
authors.forename: Alexandre
authors.initials: A
authors.lastname: de Mendonça
authors.forename: Rodrigo A
authors.initials: RA
authors.lastname: Cunha
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D002110:Caffeine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*
chemical_list: D018696:Neuroprotective Agents; D002110:Caffeine